Panacea Biotec Pharma Limited
Indian Pharmaceutical Exporter ยท Immunosuppressants Specialist ยท $23.9M Total Trade ยท DGFT Verified
Panacea Biotec Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $23.9M across 13 products in 9 therapeutic categories. Based on 580 verified export shipments from Indian Customs (DGFT) records, Panacea Biotec Pharma Limited is the #1 Indian exporter in 3 products including Protein, Glucosamine, Chondroitin. Top exports include Tacrolimus ($5.2M), Paclitaxel ($3.3M), Protein ($3.0M).
Panacea Biotec Pharma Limited โ Export Portfolio & Destination Treemap

Who is Panacea Biotec Pharma Limited? โ Company Overview & Market Position
Panacea Biotec Pharma Limited, established in 1984 as Panacea Drugs Private Limited, is a prominent Indian pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. The company is headquartered in New Delhi, India, with additional offices in Mumbai and Lalru (near Chandigarh). Incorporated as a public limited company on 22 March 2019, it operates under the Corporate Identification Number (CIN) U24299DL2019PLC347566. As of 2025, Panacea Biotec reported a revenue of approximately $66.8 million, reflecting a 21.6% increase from the previous year. The company employs around 1,290 individuals, underscoring its significant presence in the pharmaceutical sector. For more information, visit their official website at www.panaceabiotec.com.